Deerfield Management’s Edwards Lifesciences EW Stock Holding History

Deerfield Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Hold	13,702	–	–	0.01%	77
2026 Q1	$1.1M	Hold	13,702	–	–	0.01%	74
2025 Q4	$1.17M	Buy	13,702 +7,353	+116%	+$603K	0.01%	117
2025 Q3	$494K	Buy	+6,349	New	+$496K	0.01%	133
2024 Q4	–	Sell	-10,332	Closed	-$682K	–	222
2024 Q3	$682K	Buy	+10,332	New	+$751K	0.01%	233
2015 Q4	–	Sell	-582,714	Closed	-$13.8M	–	116
2015 Q3	$13.8M	Sell	582,714 -688,386	-54%	-$16.6M	0.53%	61
2015 Q2	$30.2M	Buy	+1,271,100	New	+$28.7M	1.01%	36
2015 Q1	–	Sell	-60,000	Closed	-$1.27M	–	126
2014 Q4	$1.27M	Buy	+60,000	New	+$1.21M	0.05%	103

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Deerfield Management's EW Position: Q2 2026 in Review

Deerfield Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 13,702 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #77.

Deerfield Management first reported a position in EW in Q4 2014 and has held it in 8 quarters since. The position peaked at $30.2M in Q2 2015. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Deerfield Management held 13,702 shares of Edwards Lifesciences worth $1.24M as of Q2 2026.
Deerfield Management left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.01% of Deerfield Management's portfolio in Q2 2026, its #77 holding.
Deerfield Management first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 8 quarters since.
Deerfield Management's Edwards Lifesciences position peaked at $30.2M in Q2 2015.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.